As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
It’s UFA week in Washington
